The Susan F. Smith Center for Women's Cancers Breast Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) provides state-of-the-art care for breast cancer patients. Our breast cancer clinicians are committed to providing you with the best and most individualized treatment options available, taking advantage of the full range of services of a top-ranked cancer hospital and research center.
Our team of breast cancer experts at the Susan F. Smith Center for Women's Cancers Breast Oncology Program includes breast cancer surgeons, medical oncologists and radiation oncologists who have pioneered the most effective techniques in breast cancer treatment.
There is no "one size fits all" treatment for breast cancer – we create personalized treatment plans based on your individual needs and the genetic make-up of your particular cancer.
Find out about our experience and approach to diagnosing and treating breast cancer.
We also offer a variety of focused programs with special expertise:
A team of experts, led by Beth Overmoyer, MD, specializes in treating inflammatory breast cancer (IBC), a rare but aggressive form of breast cancer. Dana-Farber/Brigham and Women’s Hospital Cancer Center hosts the only program in the Northeast focused solely on IBC.
Young women (in their early 40s and younger) with breast cancer face particular challenges and need different resources. Combining treatment, research, and specialized support services, our Program for Young Women with Breast Cancer, led by Ann Partridge, MD, MPH, is one of the few programs in the country designed to meet the needs of young women faced with a breast cancer diagnosis.
Treating patients with metastatic breast cancer (MBC) is a significant part of our practice at Dana-Farber/Brigham and Women's Breast Oncology Program. Our doctors, nurses, nutritionists, research staff, social workers, and others provide continuous care, support, and assistance. We are committed to providing each patient with the best and most personalized treatment options available, taking advantage of the full range of services of a top-ranked cancer hospital and research center.
Every year in the United States, one in 3,000 women will be diagnosed with breast cancer during pregnancy. Our clinicians at the Breast Cancer during Pregnancy Program, led by Erica Mayer, MD, MPH, are leaders in achieving healthy outcomes for pregnant women with breast cancer and their babies. The team includes some of the world’s most experienced and respected breast cancer oncologists and maternal-fetal specialists in Obstetrics/Gynecology.
If you or your doctor thinks you are at high risk of developing breast or ovarian cancer, the Cancer Genetics and Prevention Program, led by Dr. Judy Garber, MD, MPH, will create a personalized program to estimate your risk as accurately as possible and work with you and your clinical team to lower your risk as much as possible.
Breast cancer is often thought of as a disease that affects only women, but men can be diagnosed with breast cancer, too. Our Male Breast Cancer Program is dedicated to the unique needs of men. Our specialists will work with you to develop a treatment plan that supports your medical and emotional needs.
At Dana-Farber/Brigham and Woman's Cancer Center’s Breast Oncology Program, our multi-disciplinary team works closely with patients, providing the resources and close cooperation of many specialists with deep expertise in diagnosing and treating breast cancer. Our physician-scientists are also researching and developing new and effective treatments for breast cancer, including clinical trials.
Having representatives from medical oncology, surgical oncology and radiation oncology working together to coordinate your care ensures that all feasible approaches to treatment will be considered, and that you will receive the combination of treatments that is best for you.
Dirk Iglehart, MD, Director of the Women's Cancers Program
Eric Winer, MD, Director of the Breast Oncology Program
Judy Garber, MD, MPH, Director, Cancer Genetics and Prevention Program
Mehra Golshan, MD, Director of Breast Surgical Services
Nancy Lin, MD, Clinical Director, Breast Oncology Program
Jay Harris, MD, Chair of Radiation Oncology
Craig Bunnell, MD, MPHHarold Burstein, MD, PhDWendy Chen, MD, MPHRachel Freedman, MD, MPHJudy Garber, MD, MPHMichael Hassett, MDIan Krop, MD, PhDJennifer Ligibel, MDNancy Lin, MDErica Mayer, MD, MPHSusan Moody, MD, PhDDaniel Morganstern, MDBeth Overmoyer, MDLeroy Parker, MDAnn Partridge, MDRochelle Scheib, MDLawrence Shulman, MDDaniel P. Silver, MD, PhDSara Tolaney, MD, MPHEric Winer, MD Rachel L. Yung, MD
Jennifer Bellon, MDJay Harris, MDSusan M. Pierce, MDRinaa S. Punglia, MD, MPHJulia Wong, MD
Susan Block, MD
Katherina Zabicki Calvillo, MD, FACSKatharine Carter, MDRoger Christian, MDLaura Dominici, MDMargaret Duggan, MDMehra Golshan, MDDirk Iglehart, MDFaina Nakhlis, MDEsther Rhei, MDSusan Troyan, MD
Christine Agius, NPAnne Kelly, RN, NPGeorgia Litsas, NPJennifer McKenna, NPHolly O'Kane, NPKaren Pollard, NPElahe Salehi, NPKaren Schulte, NP
Erin Hagemeister, RNMargaret Haldoupis, RNJudith Hirshfield-Bartek, RNElizabeth Kasparian, RNMary O'Driscoll, RNKathleen Roche, RNMyra St. Amand, RN
Rachel Allende, LICSW (Spanish- and Portuguese-speaking patients)Elizabeth Farrell, LCSWPatricia Kartiganer, LICSWShivani Kaushik, MSW (Inpatient)Julie Salinger, LCSW
We believe outstanding clinical care is directly linked to an active program of clinical research. Our physician-scientists take the questions that arise in their clinical practices, answer them through clinical trials, and take this new knowledge back to the clinic where it can immediately benefit patients.
Breast cancer investigators are tackling cancer on multiple fronts, including triple-negative breast cancers, HER2-positive breast tumors that have become resistant to Herceptin, and targeted therapies for metastatic breast cancer.
Dana-Farber/Brigham and Women’s Cancer Center’s Breast Oncology Program provides breast cancer patients access to more than 40 clinical trials at a time — many of which are changing the standard of care worldwide and are not available elsewhere. Our clinical trials focus on the types and phases of your disease so therapy can be targeted to your type of breast cancer.
SearchClinical trials for early stage breast cancerClinical trials for metastatic breast cancerClinical trials for breast cancer prevention
Dana-Farber remains true to Dr. Sidney Farber's vision of a cancer center as dedicated to discoveries in cancer research as it is to delivering compassionate, patient-centered care. Through strategic investment in research, we support scientific leaders and young investigators, acquire technology at the leading edge of cancer research, and ensure a spirit of collaboration and innovation.
Read about our recent Breast Cancer Research Advances
If you have never been seen before at Dana-Farber/Brigham and Women's Cancer Center, please call 877-442-3324 or use this online form to make an appointment.
Referring physicians: 617-632-2175
For all other inquiries, please call 617-632-3800.
Susan F. Smith Center for Women's CancersBreast Oncology ProgramDana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
Dana-Farber/New Hampshire Oncology-Hematology (second opinions only)
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: